Literature DB >> 27458054

TRIM32 ubiquitin E3 ligase, one enzyme for several pathologies: From muscular dystrophy to tumours.

Elisa Lazzari1, Germana Meroni2.   

Abstract

TRIM32 is a member of the TRIpartite Motif family characterised by the presence of an N-terminal three-domain-module that includes a RING domain, which confers E3 ubiquitin ligase activity, one or two B-box domains and a Coiled-Coil region that mediates oligomerisation. Several TRIM32 substrates were identified including muscular proteins and proteins involved in cell cycle regulation and cell motility. As ubiquitination is a versatile post-translational modification that can affect target turnover, sub-cellular localisation or activity, it is likely that diverse substrates may be differentially affected by TRIM32-mediated ubiquitination, reflecting its multi-faceted roles in muscle physiology, cancer and immunity. With particular relevance for muscle physiology, mutations in TRIM32 are associated with autosomal recessive Limb-Girdle Muscular Dystrophy 2H, a muscle-wasting disease with variable clinical spectrum ranging from almost asymptomatic to wheelchair-bound patients. In this review, we will focus on the ability of TRIM32 to mark specific substrates for proteasomal degradation discussing how the TRIM32-proteasome axis may (i) be important for muscle homeostasis and for the pathogenesis of muscular dystrophy; and (ii) define either an oncogenic or tumour suppressive role for TRIM32 in the context of different types of cancer.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Muscle physiology and regeneration; Proteasome; TRIM; Ubiquitin E3 ligases

Mesh:

Substances:

Year:  2016        PMID: 27458054     DOI: 10.1016/j.biocel.2016.07.023

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  19 in total

1.  TRIM32, but not its muscular dystrophy-associated mutant, positively regulates and is targeted to autophagic degradation by p62/SQSTM1.

Authors:  Katrine Stange Overå; Juncal Garcia-Garcia; Zambarlal Bhujabal; Ashish Jain; Aud Øvervatn; Kenneth Bowitz Larsen; Vojo Deretic; Terje Johansen; Trond Lamark; Eva Sjøttem
Journal:  J Cell Sci       Date:  2019-12-02       Impact factor: 5.285

2.  Drosophila TRIM32 cooperates with glycolytic enzymes to promote cell growth.

Authors:  Simranjot Bawa; David S Brooks; Kathryn E Neville; Marla Tipping; Md Abdul Sagar; Joseph A Kollhoff; Geetanjali Chawla; Brian V Geisbrecht; Jason M Tennessen; Kevin W Eliceiri; Erika R Geisbrecht
Journal:  Elife       Date:  2020-03-30       Impact factor: 8.140

3.  Mouse models of two missense mutations in actin-binding domain 1 of dystrophin associated with Duchenne or Becker muscular dystrophy.

Authors:  Jackie L McCourt; Dana M Talsness; Angus Lindsay; Robert W Arpke; Paul D Chatterton; D'anna M Nelson; Christopher M Chamberlain; John T Olthoff; Joseph J Belanto; Preston M McCourt; Michael Kyba; Dawn A Lowe; James M Ervasti
Journal:  Hum Mol Genet       Date:  2018-02-01       Impact factor: 6.150

4.  Trim32 suppresses cerebellar development and tumorigenesis by degrading Gli1/sonic hedgehog signaling.

Authors:  Minglei Wang; Wenqin Luo; Yu Zhang; Rong Yang; Xuefeng Li; Yanjing Guo; Chenlu Zhang; Ru Yang; Wei-Qiang Gao
Journal:  Cell Death Differ       Date:  2019-09-17       Impact factor: 15.828

5.  EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer.

Authors:  Ke Gong; Gao Guo; Nishah Panchani; Matthew E Bender; David E Gerber; John D Minna; Farjana Fattah; Boning Gao; Michael Peyton; Kemp Kernstine; Bipasha Mukherjee; Sandeep Burma; Cheng-Ming Chiang; Shanrong Zhang; Adwait Amod Sathe; Chao Xing; Kathryn H Dao; Dawen Zhao; Esra A Akbay; Amyn A Habib
Journal:  Nat Cancer       Date:  2020-04-06

6.  E3 ubiquitin ligase, RNF139, inhibits the progression of tongue cancer.

Authors:  Lina Wang; Wei Yin; Chun Shi
Journal:  BMC Cancer       Date:  2017-06-29       Impact factor: 4.430

7.  TRIM59 induces epithelial-to-mesenchymal transition and promotes migration and invasion by PI3K/AKT signaling pathway in medulloblastoma.

Authors:  Ran Gao; Guoqing Lv; Cuicui Zhang; Xiaoli Wang; Lijing Chen
Journal:  Oncol Lett       Date:  2018-04-04       Impact factor: 2.967

8.  Thin is required for cell death in the Drosophila abdominal muscles by targeting DIAP1.

Authors:  Kumar Vishal; Simranjot Bawa; David Brooks; Kenneth Bauman; Erika R Geisbrecht
Journal:  Cell Death Dis       Date:  2018-07-03       Impact factor: 8.469

9.  Autophagy induction in atrophic muscle cells requires ULK1 activation by TRIM32 through unanchored K63-linked polyubiquitin chains.

Authors:  M Di Rienzo; M Antonioli; C Fusco; Y Liu; M Mari; I Orhon; G Refolo; F Germani; M Corazzari; A Romagnoli; F Ciccosanti; B Mandriani; M T Pellico; R De La Torre; H Ding; M Dentice; M Neri; A Ferlini; F Reggiori; M Kulesz-Martin; M Piacentini; G Merla; G M Fimia
Journal:  Sci Adv       Date:  2019-05-08       Impact factor: 14.136

10.  TRIM32 affects the recovery of motor function following spinal cord injury through regulating proliferation of glia.

Authors:  Qiang Fu; Ming-Ming Zou; Jian-Wei Zhu; Yan Zhang; Wen-Jin Chen; Mei Cheng; Chun-Feng Liu; Quan-Hong Ma; Ru-Xiang Xu
Journal:  Oncotarget       Date:  2017-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.